Fogel Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-8,904
Closed -$1.01M 42
2024
Q3
$1.01M Buy
8,904
+3,755
+73% +$446K 0.52% 26
2024
Q2
$637K Buy
5,149
+1,430
+38% +$184K 0.34% 27
2024
Q1
$474K Buy
3,719
+401
+12% +$49.4K 0.28% 27
2023
Q4
$420K Buy
+3,318
New +$344K 0.32% 25

Other funds holding MRK

Fogel Capital Management's MRK Position: Q4 2024 in Review

Fogel Capital Management sold out of Merck (MRK) in Q4 2024, closing a stake of 8,904 shares — an estimated $1.01M sold.

Fogel Capital Management first reported a position in MRK in Q4 2023 and held it in 4 quarters. The position peaked at $1.01M in Q3 2024. 3,607 funds tracked by Wall St. Rank hold MRK as of Q4 2024.

  • Fogel Capital Management reported no remaining Merck position as of Q4 2024 after selling out during the quarter.
  • Fogel Capital Management sold 8,904 Merck shares in Q4 2024, an estimated $1.01M.
  • Fogel Capital Management first reported a position in Merck in Q4 2023 and held it in 4 quarters.
  • Fogel Capital Management's Merck position peaked at $1.01M in Q3 2024.
  • 3,607 funds tracked by Wall St. Rank held Merck as of Q4 2024.

Based on Fogel Capital Management's 13F filing for Q4 2024, filed 27 Jan 2025.